CQP(SZ:000950)2023-04-26 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥19,620,276,794.03, representing a 23.56% increase compared to ¥15,878,655,477.15 in the same period last year[7]. - Net profit attributable to shareholders was ¥166,044,332.35, up 48.40% from ¥111,888,762.43 year-on-year[7]. - The net profit after deducting non-recurring gains and losses was ¥149,020,220.06, a significant increase of 149.12% from ¥59,818,669.95 in the previous year[7]. - The total operating revenue for Q1 2023 was CNY 19,620,276,794.03, an increase of 23.3% compared to CNY 15,878,655,477.15 in the same period last year[36]. - The net profit for Q1 2023 reached CNY 231,764,045.24, representing a 60.7% increase from CNY 144,327,904.72 in Q1 2022[38]. - The total comprehensive income for the period amounted to ¥231,764,045.24, compared to ¥144,327,904.72 in the previous period, reflecting a significant increase[39]. - The net income attributable to the parent company was ¥166,044,332.35, up from ¥111,888,762.43 year-over-year[39]. - Basic and diluted earnings per share both increased to ¥0.10 from ¥0.06 in the previous period[39]. Assets and Liabilities - The company's total assets at the end of the reporting period were ¥60,795,703,509.72, reflecting a 6.30% increase from ¥57,191,648,432.88 at the end of the previous year[7]. - The total liabilities as of Q1 2023 amounted to CNY 47,669,938,424.95, an increase from CNY 44,481,256,335.77 in the previous year[36]. - The total liabilities increased, with short-term borrowings reaching 15,105,286,336.39 RMB compared to 14,772,107,320.83 RMB previously[27]. - The company reported a significant increase in other receivables, which rose to 1,331,638,771.54 RMB from 1,131,343,680.69 RMB[27]. Cash Flow - The net cash flow from operating activities was -¥3,093,724,213.10, a 2.07% improvement from -¥3,159,107,305.23 in the previous year[19]. - The cash inflow from operating activities was CNY 18,152,138,655.52, compared to CNY 15,384,982,283.54 in the previous year, marking an increase of 18.2%[32]. - The net cash flow from investing activities decreased by 54.10% year-on-year, primarily due to a reduction in the amount from the sale of stock in International Potash[20]. - The net cash flow from financing activities decreased by 48.49% year-on-year, mainly due to an increase in the repayment of external financing as part of debt structure adjustments[20]. - The company reported a total cash outflow from operating activities of ¥21,245,862,868.62, compared to ¥18,544,089,588.77 in the previous year[43]. - Cash flow from investing activities showed a net inflow of ¥34,079,014.17, compared to ¥74,238,524.35 in the previous year[43]. - Cash flow from financing activities resulted in a net inflow of ¥1,330,850,572.46, down from ¥2,583,847,229.80 year-over-year[43]. Operational Highlights - Accounts receivable increased by 17.03% to ¥33,331,470,842.64, primarily due to concentrated settlements at the end of the previous year and new consolidated entities[12]. - Inventory rose by 4.55% to ¥8,220,329,741.18, driven by business expansion and stockpiling in response to procurement policies[13]. - The company continued to enhance its digital capabilities and organizational structure, leading to improved logistics and marketing capabilities[11]. - The company plans to accelerate its investment and acquisition projects to further expand its market presence[11]. - Research and development expenses increased significantly to CNY 1,497,098.60 from CNY 76,038.11, indicating a focus on innovation[38]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 43,504[21]. - The largest shareholder, Chongqing Pharmaceutical Health, holds 38.14% of the shares, totaling 664,900,806 shares[21]. Financial Expenses - The financial expenses increased by 25.37% to ¥328,473,998.37, mainly due to the issuance of asset securitization products[16]. - The company’s financial expenses rose to CNY 328,473,998.37 from CNY 262,001,662.52, reflecting increased borrowing costs[38]. Audit and Reporting - The company did not undergo an audit for the first quarter report[44]. - The report was released by the board of directors on April 27, 2023[45].